Leukemia stemness and co-occurring mutations drive resistance to IDH inhibitors in acute myeloid leukemia.
Wang F, Morita K, DiNardo CD, Furudate K, Tanaka T, Yan Y, Patel KP, MacBeth KJ, Wu B, Liu G, Frattini M, Matthews JA, Little LD, Gumbs C, Song X, Zhang J, Thompson EJ, Kadia TM, Garcia-Manero G, Jabbour E, Ravandi F, Bhalla KN, Konopleva M, Kantarjian HM, Andrew Futreal P, Takahashi K.
Wang F, et al. Among authors: dinardo cd.
Nat Commun. 2021 May 10;12(1):2607. doi: 10.1038/s41467-021-22874-x.
Nat Commun. 2021.
PMID: 33972549
Free PMC article.